Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis

被引:111
|
作者
Goldman, Jeremy
Rutkowski, Joseph M.
Shields, Jacqueline D.
Pasquier, Miriella C.
Cui, Yingjie
Schmoekel, Hugo G.
Willey, Stephen
Hicklin, Daniel J.
Pytowski, Bronislaw
Swartz, Melody A.
机构
[1] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Life Sci, LMBM, CH-1015 Lausanne, Switzerland
[2] Tumor Biol ImClone Syst, New York, NY USA
[3] ImClone Syst, Expt Therapeut, New York, NY USA
来源
FASEB JOURNAL | 2007年 / 21卷 / 04期
关键词
VEGF-C; mouse; in vitro wound healing; vasculogenesis;
D O I
10.1096/fj.06-6656com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of vascular endothelial growth factor ( VEGF) receptor-3 (VEGFR-3) by VEGF-C initiates lymphangiogenesis by promoting lymphatic proliferation and migration. However, it is unclear whether VEGFR-3 signaling is required beyond these initial stages, namely during the organization of new lymphatic endothelial cells (LECs) into functional capillaries. Furthermore, the role of VEGFR-2, which is also expressed on LECs and binds VEGF-C, is unclear. We addressed these questions by selectively neutralizing VEGFR-3 and/or VEGFR-2 for various time periods in an adult model of lymphangiogenesis in regenerating skin. While blocking either VEGFR-2 or VEGFR-3 with specific antagonist mAbs (DC101 and mF4-31C1, respectively) prior to lymphatic migration prevented lymphangiogenesis, blocking VEGFR-3 subsequent to migration did not affect organization into functional capillaries, and VEGFR-2 blocking had only a small hindrance on organization. These findings were confirmed in vitro using human LECs and anti-human antagonist mAbs (IMC-1121a and hF4-3C5): both VEGFR-2 and VEGFR-3 signaling were required for migration and proliferation, but tubulogenesis in 3D cultures was unaffected by VEGFR-3 blocking and partially hindered by VEGFR-2 blocking. Furthermore, both in vitro and in vivo, while VEGFR-3 blocking had no effect on LEC organization, coneutralization of VEGFR-2, and VEGFR- 3 completely prevented lymphatic organization. Our findings demonstrate that cooperative signaling of VEGFR-2 and -3 is necessary for lymphatic migration and proliferation, but VEGFR-3 is redundant with VEGFR-2 for LEC organization into functional capillaries.
引用
收藏
页码:1003 / 1012
页数:10
相关论文
共 50 条
  • [31] Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development
    Saharinen, Pipsa
    Helotera, Hanna
    Miettinen, Juho
    Norrmen, Camilla
    D'Amico, Gabriela
    Jeltsch, Michael
    Langenberg, Tobias
    Vandevelde, Wouter
    Ny, Annelii
    Dewerchin, Mieke
    Carmeliet, Peter
    Alitalo, Kari
    [J]. GENES & DEVELOPMENT, 2010, 24 (09) : 875 - 880
  • [32] VEGFR-3 signalling mediates lymphangiogenesis and alloimune reactions in cardiac allograffs
    Nykanen, A. L.
    Sandelin, H.
    Keranen, M. A. I.
    Tuuminen, R.
    Koskinen, P. K.
    Alitalo, K.
    Lemstrom, K. B.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S159 - S159
  • [33] Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation
    Huggenberger, Reto
    Ullmann, Stefan
    Proulx, Steven T.
    Pytowski, Bronislaw
    Alitalo, Kari
    Detmar, Michael
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (10): : 2255 - 2269
  • [34] VEGFR-3 mediates lymphangiogenesis and alloimmune responses in cardiac allografts.
    Sandelin, Henrik
    Nykanen, Antti I.
    Keranen, Mikko A. I.
    Tuuminen, Raimo
    Koskinen, Petri K.
    Alitalo, Kati
    Lemstrom, Karl B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 315 - 315
  • [35] Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice.
    Jussila, L
    Veikkola, T
    Jeltsch, M
    Thurston, G
    McDonald, D
    Achen, M
    Stacker, S
    Alitalo, K
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3762S - 3762S
  • [36] Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
    Padera, Timothy P.
    Kuo, Angera H.
    Hoshida, Tohru
    Liao, Shan
    Lobo, Jennifer
    Kozak, Kevin R.
    Fukumura, Dai
    Jain, Rakesh K.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) : 2272 - 2279
  • [37] VEGFR-3 directly interacts with PI3K to regulate lymphangiogenesis
    Coso, Sanja
    Zeng, Yiping
    Opeskin, Kenneth
    Williams, Elizabeth D.
    [J]. VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 367 - 367
  • [38] Heterodimerisation between VEGFR-1 and VEGFR-2 and not the homodimers of VEGFR-1 inhibit VEGFR-2 activity
    Cai, Meng
    Wang, Keqing
    Murdoch, Colin E.
    Gu, Yuchun
    Ahmed, Asif
    [J]. VASCULAR PHARMACOLOGY, 2017, 88 : 11 - 20
  • [39] Progress in The Study of VEGFR-2 Signaling Pathway
    Kang Cong-Min
    Wang Da-Wei
    Lue Ying-Tao
    Zhang Yuan-Yuan
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2009, 36 (10) : 1267 - 1274
  • [40] VEGF receptor signaling in lymphangiogenesis: Cooperative and redundant roles
    Rutkowski, J. M.
    Shields, J. D.
    Goldman, J.
    Swartz, M. A.
    [J]. JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 84 - 84